These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 31257722)

  • 41. Multifunctional plant virus nanoparticles: An emerging strategy for therapy of cancer.
    Azizi M; Shahgolzari M; Fathi-Karkan S; Ghasemi M; Samadian H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(6):e1872. PubMed ID: 36450366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic and Therapeutic Nanomedicine.
    Joo J
    Adv Exp Med Biol; 2021; 1310():401-447. PubMed ID: 33834444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultrasmall silica nanoparticles in translational biomedical research: Overview and outlook.
    Singh N; Shi S; Goel S
    Adv Drug Deliv Rev; 2023 Jan; 192():114638. PubMed ID: 36462644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NCI investment in nanotechnology: achievements and challenges for the future.
    Dickherber A; Morris SA; Grodzinski P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(3):251-65. PubMed ID: 25429991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imaging applications of nanotechnology in cancer.
    Gunasekera UA; Pankhurst QA; Douek M
    Target Oncol; 2009 Sep; 4(3):169-81. PubMed ID: 19876702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Challenges in the development of nanoparticle-based imaging agents: Characterization and biology.
    Crist RM; Dasa SSK; Liu CH; Clogston JD; Dobrovolskaia MA; Stern ST
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1665. PubMed ID: 32830448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanotechnology based therapeutics for lung disease.
    Doroudian M; MacLoughlin R; Poynton F; Prina-Mello A; Donnelly SC
    Thorax; 2019 Oct; 74(10):965-976. PubMed ID: 31285360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology.
    Hauert S; Bhatia SN
    Trends Biotechnol; 2014 Sep; 32(9):448-55. PubMed ID: 25086728
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The nanotechnology as a support for diagnosis and prognosis in cancer research].
    Romero-Morelos P; Peralta-Rodríguez R; Mendoza-Rodríguez M; Valdivia-Flores A; Marrero-Rodríguez D; Paniagua-García L; Rodríguez-Cabrales J; Parra-Melquiádez M; Salcedo-Vargas M
    Rev Med Inst Mex Seguro Soc; 2011; 49(6):621-30. PubMed ID: 22176824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report.
    Bertagnolli MM; Blanke CD; Curran WJ; Hawkins DS; Mannel RS; O'Dwyer PJ; Schnall MD; Wolmark N
    Cancer; 2020 Dec; 126(23):5022-5029. PubMed ID: 32970346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Embracing nanomaterials' interactions with the innate immune system.
    Teunissen AJP; Burnett ME; Prévot G; Klein ED; Bivona D; Mulder WJM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1719. PubMed ID: 33847441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanoinformatics and DNA-based computing: catalyzing nanomedicine.
    Maojo V; Martin-Sanchez F; Kulikowski C; Rodriguez-Paton A; Fritts M
    Pediatr Res; 2010 May; 67(5):481-9. PubMed ID: 20118825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The NCI Community Oncology Research Program: what every clinician needs to know.
    McCaskill-Stevens W; Lyss AP; Good M; Marsland T; Lilenbaum R
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer nanotechnology research in the United States and China: cooperation to promote innovation.
    Schneider JA; Grodzinski P; Liang XJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(5):441-448. PubMed ID: 21656699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanotechnologies for biomedical science and translational medicine.
    Heath JR
    Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14436-43. PubMed ID: 26598663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology.
    Domingues C; Santos A; Alvarez-Lorenzo C; Concheiro A; Jarak I; Veiga F; Barbosa I; Dourado M; Figueiras A
    ACS Nano; 2022 Jul; 16(7):9994-10041. PubMed ID: 35729778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program.
    Dimond EP; St Germain D; Nacpil LM; Zaren HA; Swanson SM; Minnick C; Carrigan A; Denicoff AM; Igo KE; Acoba JD; Gonzalez MM; McCaskill-Stevens W
    Clin Trials; 2015 Jun; 12(3):246-56. PubMed ID: 25691600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toward the emergence of nanoneurosurgery: part III--nanomedicine: targeted nanotherapy, nanosurgery, and progress toward the realization of nanoneurosurgery.
    Leary SP; Liu CY; Apuzzo ML
    Neurosurgery; 2006 Jun; 58(6):1009-26; discussion 1009-26. PubMed ID: 16723880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nanodiagnostics and Nanodelivery Applications in Genetic Alterations.
    Falzarano MS; Flesia C; Cavalli R; Guiot C; Ferlini A
    Curr Pharm Des; 2018; 24(15):1717-1726. PubMed ID: 29318963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures.
    He H; Liu L; Morin EE; Liu M; Schwendeman A
    Acc Chem Res; 2019 Sep; 52(9):2445-2461. PubMed ID: 31424909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.